European Medical Solutions has the GF Score of 51, which implies that the company
might have
Poor future performance potential.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes European Medical Solutions
might have
Poor future performance potential.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
European Medical Solutions (STU:AS00) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
European Medical Solutions GF Score Related Terms
STU:AS00 vs VRTX, REGN, ALNY: GF Score Comparison
For the Biotechnology subindustry, European Medical Solutions's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
European Medical Solutions GF Score vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, European Medical Solutions's GF Score distribution charts can be found below:
* The bar in red indicates where European Medical Solutions's GF Score falls into.
European Medical Solutions (STU:AS00) has a GF Score of 51 as of Jul. 04, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on European Medical Solutions and its competitors. This is 104% above median its historical median of 25.00. Over the past decade, European Medical Solutions' GF Score has ranged from 16.00 to 60.00.
Is European Medical Solutions' GF Score too high?
European Medical Solutions' current GF Score of 51 is 104% above median its 10-year median of 25.00. Over the past 10 years, this metric has ranged from a low of 16.00 to a high of 60.00. Overall, European Medical Solutions has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does European Medical Solutions' GF Score compare to VRTX and REGN?
European Medical Solutions' GF Score of 51 can be compared against companies in the Biotechnology industry. Historically, European Medical Solutions' own GF Score has ranged from 16.00 to 60.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Biotechnology company?
A good GF Score depends on the Biotechnology industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on European Medical Solutions and its competitors. European Medical Solutions's current GF Score is 51, which is 104% above median its own 10-year median of 25.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is European Medical Solutions stock overvalued right now?
European Medical Solutions (STU:AS00) has a current GF Score of 51. The stock's GF Value™ is €8.11, compared to a current price of €4.72 — trading 41.8% below its estimated fair value. The current GF Score is 51, which is 104% above median its 10-year median of 25.00. European Medical Solutions' overall GF Score™ is 51/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For European Medical Solutions (STU:AS00), the current GF Score is 51 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is European Medical Solutions (STU:AS00) Overvalued in 2026?
Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued.
The current stock price of €4.72 is trading 41.8% below its estimated GF Value™ of €8.11.
Key valuation signals for STU:AS00:
GF Score: 51 (104% above median its 10-year median of 25.00)
GF Value™: €8.11 vs. price of €4.72 (41.8% below fair value)
No single metric tells the full story. See the STU:AS00 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
51GF Score
Get the complete analysis for STU:AS00
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:AS00 has been successfully added to your 